These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 31883519

  • 1. Dose-response relationship of ICS/fast-onset LABA as reliever therapy in asthma.
    Beasley R, Harper J, Bird G, Dunphy H, Semprini A, Pavord ID, Papi A, Weatherall M.
    BMC Pulm Med; 2019 Dec 28; 19(1):264. PubMed ID: 31883519
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Overall asthma control: the relationship between current control and future risk.
    Bateman ED, Reddel HK, Eriksson G, Peterson S, Ostlund O, Sears MR, Jenkins C, Humbert M, Buhl R, Harrison TW, Quirce S, O'Byrne PM.
    J Allergy Clin Immunol; 2010 Mar 28; 125(3):600-8, 608.e1-608.e6. PubMed ID: 20153029
    [Abstract] [Full Text] [Related]

  • 10. Symbicort® Maintenance and Reliever Therapy (SMART) and the evolution of asthma management within the GINA guidelines.
    Lin J, Zhou X, Wang C, Liu C, Cai S, Huang M.
    Expert Rev Respir Med; 2018 Mar 28; 12(3):191-202. PubMed ID: 29400090
    [Abstract] [Full Text] [Related]

  • 11. Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps.
    Bateman ED, Harrison TW, Quirce S, Reddel HK, Buhl R, Humbert M, Jenkins CR, Peterson S, Ostlund O, O'Byrne PM, Sears MR, Eriksson GS.
    Respir Res; 2011 Apr 04; 12(1):38. PubMed ID: 21463522
    [Abstract] [Full Text] [Related]

  • 12. Budesonide/formoterol maintenance and reliever therapy versus conventional best practice.
    Demoly P, Louis R, Søes-Petersen U, Naya I, Carlsheimer A, Worth H, Almeida J, Sears MR.
    Respir Med; 2009 Nov 04; 103(11):1623-32. PubMed ID: 19762222
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone.
    Bousquet J, Boulet LP, Peters MJ, Magnussen H, Quiralte J, Martinez-Aguilar NE, Carlsheimer A.
    Respir Med; 2007 Dec 04; 101(12):2437-46. PubMed ID: 17905575
    [Abstract] [Full Text] [Related]

  • 15. Achieving asthma control with ICS/LABA: A review of strategies for asthma management and prevention.
    Aalbers R, Vogelmeier C, Kuna P.
    Respir Med; 2016 Feb 04; 111():1-7. PubMed ID: 26614594
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of Budesonide-Formoterol for Maintenance and Reliever Therapy Among Patients With Poorly Controlled Asthma: A Systematic Review and Meta-analysis.
    Beasley R, Harrison T, Peterson S, Gustafson P, Hamblin A, Bengtsson T, Fagerås M.
    JAMA Netw Open; 2022 Mar 01; 5(3):e220615. PubMed ID: 35230437
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparing the efficacy and safety of formoterol/budesonide pMDI versus its mono-components and other LABA/ICS in patients with asthma.
    Mukhopadhyay A, Waked M, Gogtay J, Gaur V.
    Respir Med; 2020 Mar 01; 170():106055. PubMed ID: 32843176
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. As-needed ICS-LABA in Mild Asthma: What Does the Evidence Say?
    Domingo C, Rello J, Sogo A.
    Drugs; 2019 Nov 01; 79(16):1729-1737. PubMed ID: 31584145
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.